Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2025-12-25 @ 4:33 AM
NCT ID:
NCT06971718
Eligibility Criteria:
Inclusion Criteria:
* Age 18 or over
* Any bifurcation lesion amenable to a provisional main vessel treatment strategy
* A main vessel diameter of 2.5mm or more and side branch diameter of \>2mm
* Any patient with stable angina, silent ischaemia, unstable angina or NSTEMI
* Able to give informed consent
Exclusion Criteria:
* Cardiogenic shock
* LVEF \<30%
* STEMI (as unable to give informed consent)
* eGFR \<30
* Severe asthma contraindicating use of adenosine
* High degree AV block on 12 lead ECG precluding the use of adenosine
* Pregnancy
* Inability to consent
* Left main stem coronary bifurcation lesions
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06971718
Study Brief:
Protocol Section:
NCT06971718